Live feed08:05:00·135dPRReleasevia QuantisnowSCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan PotassiumByQuantisnow·Wall Street's wire, on your screen.SCNX· Scienture Holdings Inc.Health CareOriginal source
